142 related articles for article (PubMed ID: 15039228)
1. Antigen location contributes to the pathological features of a transplanted heart graft.
Chen Y; Demir Y; Valujskikh A; Heeger PS
Am J Pathol; 2004 Apr; 164(4):1407-15. PubMed ID: 15039228
[TBL] [Abstract][Full Text] [Related]
2. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
3. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
4. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
5. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
[TBL] [Abstract][Full Text] [Related]
6. Effects of T cell frequency and graft size on transplant outcome in mice.
He C; Schenk S; Zhang Q; Valujskikh A; Bayer J; Fairchild RL; Heeger PS
J Immunol; 2004 Jan; 172(1):240-7. PubMed ID: 14688331
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.
Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH
J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393
[TBL] [Abstract][Full Text] [Related]
8. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
9. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
[TBL] [Abstract][Full Text] [Related]
10. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
[TBL] [Abstract][Full Text] [Related]
11. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
Youssef AR; Otley C; Mathieson PW; Smith RM
Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
[TBL] [Abstract][Full Text] [Related]
12. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of innate co-receptor TREM-1 signaling reduces CD4(+) T cell activation and prolongs cardiac allograft survival.
Schiechl G; Brunner SM; Kesselring R; Martin M; Ruemmele P; Mack M; Hirt SW; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Am J Transplant; 2013 May; 13(5):1168-80. PubMed ID: 23463907
[TBL] [Abstract][Full Text] [Related]
14. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
15. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
16. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
17. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
19. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
